Removing 10% of a patient's blood before major liver surgery and giving it back afterwards reduced transfusions by half, according to a large clinical trial published in The Lancet Gastroenterology & ...
Molecular subtypes and outcomes in regorafenib-treated patients with metastatic colorectal cancer (mCRC) enrolled in the CORRECT trial. Effects of regorafenib (REG) therapy on health-related quality ...
Successful Establishment of a National Cancer Control Program (NCCP) and Cancer Registry in Eswatini: Lessons to Inform NCCPs in Low- and Mid-Income Countries An observational study following the ...
"Hepatectomy, including minor and major hepatectomy, may be safe and oncologically feasible in older patients with HCC who have few comorbidities, good liver function reserve, and good performance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback